Washington, D.C. — The Marijuana Policy Project (MPP), the nation’s leading cannabis policy reform organization, announced today that Heather Azzi has joined the leadership team as Policy Director and General Counsel.
Azzi brings over two decades of legal, regulatory, and campaign expertise back to MPP, where she previously served in multiple key roles, including Director of State Campaigns, Senior Campaign Attorney, and Political Director.
“We are thrilled to welcome Heather back to lead our policy strategy,” said Adam Smith, Executive Director of the Marijuana Policy Project. “Heather’s deep legal expertise and unparalleled track record of drafting state cannabis laws and steering complex reform campaigns make her an invaluable asset to MPP as we push to end prohibition at both the state and federal levels.”
Throughout her 20-year career in cannabis reform, Azzi has overseen operations and legal matters, compliance, and strategic management for nonprofit organizations, PACs, and campaign committees sponsoring cannabis-related reform. During her previous tenure at MPP, Azzi either led or assisted with drafting a majority of the cannabis-related laws enacted in the United States between 2007 and 2018.
Prior to rejoining MPP, Azzi served as General Counsel for the United States Cannabis Roundtable (USCR) and was also a co-founder and General Counsel for the United States Cannabis Council and the Cannabis Trade Federation. Azzi holds a J.D. from Lewis & Clark Law School in Portland, Oregon.
“I am thrilled to rejoin MPP and hit the ground running at such a pivotal moment for our movement,” said Heather Azzi, Policy Director and General Counsel at MPP. “I look forward to working alongside our talented team to draft impactful legislation, champion state and federal campaigns, and build the legal framework for a more rational, just, and equitable cannabis policy nationwide.”
Boise, ID — In a major rebuke to a smug, overreaching, and prohibitionist state legislature, Idahoans have rejected House Joint Resolution 4 (HJR 4). The proposed constitutional amendment, introduced by the state legislature, sought to restrict citizens’ ability to pass future ballot initiatives to reform any of the state’s drug laws, including those focused on medical and adult-use cannabis reform.
“Idaho voters have scored a major victory for citizen-led advocacy and common sense by soundly rejecting HJR 4. Idaho’s cannabis laws are among the most draconian in the nation, and Idahoans suffer one of the highest cannabis arrest rates in the U.S. Simple possession in the state can be punished by up to a year in jail, while a second offense can be elevated to a felony. Medical cannabis is overwhelmingly supported by Idaho voters, and this year, advocates made a nearly successful run at putting the medical issue onto the ballot. HJR 4 was the legislature’s effort to silence their constituents on this or any other common-sense drug policy reform once and for all. We applaud Idaho’s voters for sending this powerful message to their elected representatives, and we hope this leads to an even stronger effort in the coming cycle to allow voters to override their legislature’s obstinacy.” -Adam J. Smith, Executive Director at the Marijuana Policy Project.
With HJR 4 defeated, advocacy groups and grassroots organizers can continue efforts to bring cannabis policy reform directly to Idaho voters in upcoming election cycles.
Boston, MA — Ten years after voting to legalize cannabis for adults, Massachusetts residents have voted to stay the course by defeating Question 8, which would have put an end to the state’s regulated cannabis market.
By voting "No" on Question 8, residents preserved a safe, regulated, and age-gated adult-use market that has led to a 50% reduction in teen cannabis use and a nearly 90% reduction in cannabis arrests. The defeat of Question 8 will also safeguard thousands of local jobs, hundreds of millions in state and local tax revenues, and critical consumer safety protections. The defeat of Question 8 marks a historic moment as Massachusetts becomes the first state in the nation to successfully beat back an organized ballot effort to undo voter-approved adult-use cannabis legalization.
“Despite a well-funded scare campaign, Massachusetts voters have chosen common sense by defeating the ballot initiative to end the state's legal adult-use cannabis market. This outcome shows that Massachusetts voters recognize the true value of regulated cannabis markets: reducing youth access, which means significantly fewer kids using cannabis; safer access for adults to rigorously tested and properly labeled products; plummeting arrest rates, which means fewer lives needlessly disrupted and fewer tax dollars wasted; tens of thousands of new jobs, and hundreds of millions in new revenues; and a recognition of personal liberty and freedom of consciousness.” - Adam J. Smith, Executive Director at the Marijuana Policy Project.
Had Question 8 passed, it would have shuttered retail dispensaries, leading to an explosion in the unregulated and non-age-gated illicit market, and eliminated legitimate jobs and vital tax revenues.
The Marijuana Policy Project (MPP) played a leading role in the original 2016 campaign (Question 4), which legalized adult-use cannabis with 53.6% of the vote. Since legal retail sales launched in November 2018, the Commonwealth’s adult-use market has achieved significant economic and public safety milestones. The regulated market now generates over $1.6 billion in annual gross sales and yields nearly $300 million in annual state and local tax revenue, directly funding public education, local infrastructure, and social equity programs. The legal industry supports approximately 23,000 workforce jobs across cultivation, processing, testing, and retail operations statewide. Further, youth cannabis use in Massachusetts is down more than 50% since legalization, while arrests for cannabis possession are down more than 85%.
Washington, D.C. — New data released this week by the U.S. Centers for Disease Control and Prevention (CDC) shows that youth cannabis use has declined significantly following the implementation of adult-use markets.
According to the CDC data, past 30-day youth cannabis use nationwide has dropped by 44% between 2011 and 2025 — a period during which roughly half the country established legal adult-use markets.
The newest CDC data, along with state-issued data on youth cannabis use, is compiled in a new report on youth use and access in the age of legalization from the Marijuana Policy Project. MPP’s full report and state-by-state data breakdowns are available here.
Of note, government data shows a significant decrease in teens’ cannabis use post-legalization in every state with regulated adult-use markets. For example, cannabis use by high school-aged teens is down by nearly 30% since legalization in Nevada, nearly 50% in Michigan, more than 50% in Massachusetts, and nearly 60% in Arizona.
"It's simple economics,” said Adam Smith, Executive Director of the Marijuana Policy Project. “As consumers transition into a legal market, illicit operators start to go out of business. And illegal dealers are the ones who sell cannabis to kids. Licensed retailers have regulators to answer to, and everything to lose. They check ID every time.”
The reduction in youth access has been confirmed by the National Institutes of Health’s Monitoring the Future Survey, which shows a greater than 30% decrease in the number of U.S. 8th and 10th graders reporting that marijuana is “easy” or “fairly easy” to obtain since states began legalizing cannabis for adults in 2012.
What’s more, the positive impact of legal markets grows over time. Washington and Colorado were the first two states to legalize adult use markets in 2012. Since then, according to the Colorado Healthy Kids Survey, high school use has dropped by 56% in the Centennial State. And the Washington State Healthy Youth Survey shows that since 2011, current cannabis use is down 62% among 8th graders, 73% among 10th graders, and 56% among high school seniors.
Washington, D.C. — States have generated a combined total of more than $28.4 billion in tax revenue from legal adult-use cannabis sales since the first markets launched in Colorado and Washington in 2014, according to a comprehensive new state-by-state report published by the Marijuana Policy Project (MPP).
In 2025 alone, legalization states collectively generated more than $4.57 billion in cannabis tax revenue from adult-use sales, which is the most revenue generated by cannabis sales in a single year. Further, seven states collected over $200 million in adult-use cannabis taxes. Three of those states — California, Illinois, and Michigan — generated over $500 million in revenue, one of which (California) collected over $1 billion.
“At a time when pressure is building on state budgets, adult-use cannabis taxes are providing relief,” said Adam J. Smith, Executive Director at the Marijuana Policy Project. “Legal adult-use markets have become powerful economic engines, creating thousands of new jobs and small business opportunities across the country. While economic growth and state revenues aren’t the primary reasons for legalizing adult-use cannabis, the positive financial impact is undeniable. That said, it is important to keep in mind that overtaxing legal cannabis can be self-defeating, driving consumers back to the unregulated, unsafe, and untaxed illicit market, which is bad for state budgets and for public health and safety. More importantly, ending prohibition has spared hundreds of thousands of individuals the trauma of arrest and incarceration, while data shows teen cannabis use rates have actually decreased in most legal states.”
Currently, 24 states and the District of Columbia have legalized cannabis possession for adults 21 and older. With the exception of Virginia and D.C., all have legalized, regulated, and taxed cannabis sales.
Notably, states with legal, adult-use cannabis sales have allocated tax revenues to a variety of needs, including their General Funds and specific services and programs. Cannabis taxes have provided funding for Medicaid, education, school construction, housing, roads, early literacy, bullying prevention, behavioral health, alcohol and drug treatment, veterans’ services, conservation, job training, conviction expungement expenses, and reinvestment in communities that have been disproportionately affected by the war on cannabis, among many others.
MPP’s report reviews each legalization state’s adult-use cannabis tax structure, population, and year-by-year adult-use cannabis tax revenue in chronological order, based on when state-legal cannabis sales began. These figures include cannabis excise taxes and states’ standard sales taxes that are applied to cannabis. They do not include medical cannabis tax revenue.
WASHINGTON, D.C. — On Thursday, the United States Justice Department (DOJ) reclassified cannabis, moving it from Schedule I to Schedule III of the Controlled Substances Act (CSA).
Adam J. Smith, Executive Director of the Marijuana Policy Project, the nation’s leading cannabis policy reform organization, released the following statement in response to the reclassification:
"Rescheduling cannabis is a historic move towards sanity in cannabis policy. We hope that this will open the door to more medical research, inspires states to guarantee access to safe, regulated cannabinoids for patients who desperately need them, and that the regulated industry might finally be treated more fairly under the federal tax code. But a move to Schedule III stops short of the systemic change we need. It does nothing to end hundreds of thousands of possession arrests each year, nor does it do anything to fix the untenable, ongoing disconnect between federal prohibition and the regulated state markets under which more than half of American adults live. While we welcome this important step, the federal government should treat cannabis the same way it treats alcohol, which means descheduling cannabis entirely."
Background: In 2022, the Biden administration advised the U.S. Department of Health and Human Services (HHS) and the Attorney General's office to conduct a scientific review of cannabis’ schedule under the Controlled Substances Act. In August 2023, the HHS and FDA recommended that cannabis be reclassified to Schedule III. The agencies’ scientific review found that cannabis has currently accepted medical use and a lower potential for abuse than Schedule I and II drugs. The Department of Justice proposed rescheduling in 2024 and opened a public comment period shortly after. In December 2025, President Donald Trump signed an executive order directing the Attorney General to accelerate the rescheduling process. Information on the potential impacts of rescheduling is available here.
In other news, MPP released a comprehensive new report this week detailing the landscape of cannabis arrests in the United States. Based on FBI Crime Explorer data, the report examines cannabis arrest data in all 50 states and highlights a wide gap between legalization and prohibition states. The full report, including a state-by-state breakdown of arrest data, is available here.
Civil rights and criminal justice leaders call for five-party discussions to establish a clear, collaborative path forward
Harrisburg, PA — Following Governor Josh Shapiro’s inclusion of adult-use cannabis legalization in his state budget proposal for the third consecutive year, a broad coalition of Pennsylvania stakeholders, including civil liberties advocates and criminal justice reform leaders, sent a formal letter to the Governor, urging the administration to prioritize adult-use cannabis legalization this year by convening formal “five-party” leadership discussions to finally deliver this long-overdue reform.
The coalition is requesting that the Governor’s office bring together Democratic and Republican leadership from both the House and Senate's four caucuses in five-party talks to establish a clear, collaborative path forward in 2026. “Doing so would align Pennsylvania with national trends, advance economic and workforce goals, and most importantly, end the unnecessary criminalization of Pennsylvanians for simple cannabis possession and use that the public overwhelmingly agrees should no longer be punished,” the letter states.
While multiple bipartisan adult-use legalization bills have been introduced in both the House and Senate, the coalition argues that Pennsylvania continues to fall behind.
“As surrounding states implement adult-use cannabis programs, the Commonwealth is losing out on thousands of good-paying jobs, hundreds of millions in tax revenue, and significant economic development opportunities—benefits that are instead flowing across our borders. This competitive disadvantage grows more pronounced with each year of inaction.”
The letter also emphasizes that the repeated failure to enact adult-use regulations and meaningful decriminalization continues to impose profound human costs.
“Tens of thousands of Pennsylvanians are still arrested, jailed, or otherwise entangled in the criminal justice system each year for non-violent cannabis offenses—conduct that is legal and unpunished in nearly every neighboring state.”
The letter, sent to Gov. Shapiro on February 5, was signed by the following organizations: ACLU of Pennsylvania, the African American Chamber of Commerce of Pennsylvania, Doctors for Drug Policy Reform, Last Prisoner Project, Law Enforcement Action Partnership, Marijuana Policy Project, Pennsylvania Prison Society, the Public Defender Association of Pennsylvania, and Straight Ahead.
WASHINGTON, D.C. — President Trump issued an Executive Order that will move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA).
Following this news, Adam J. Smith, Executive Director of the Marijuana Policy Project, the nation’s leading cannabis policy reform organization, released the following statement:
"While MPP welcomes the President’s proposal to move cannabis from Schedule I to Schedule III, neither the plant itself nor its naturally occurring component cannabinoids belong on the schedule at all.
"We hope this move to Schedule III truly does open up medical research, that it inspires states to guarantee access to safe, regulated cannabinoids for patients who desperately need them, and that the regulated industry might finally be treated more fairly under the federal tax code. But a move to Schedule III does nothing to end hundreds of thousands of possession arrests each year, nor does it do anything to fix the untenable, ongoing disconnect between federal prohibition and the regulated state markets under which more than half of American adults live.
"We are pleased that the President is taking this important step, but it is only a step. It is long past time to deschedule cannabis entirely and end nearly a century of failed prohibition.”
Background: In 2022, the Biden administration advised the U.S. Department of Health and Human Services (HHS) and the Attorney General's office to conduct a scientific review of cannabis’ schedule under the Controlled Substances Act (CSA). In August 2023, the HHS and FDA recommended that cannabis be reclassified to Schedule III. The agencies’ scientific review found that cannabis has currently accepted medical use and a lower potential for abuse than Schedule I and II drugs. The Department of Justice proposed rescheduling in 2024 and opened a public comment period shortly after. At the end of 2024, the DEA appointed Judge John Mulrooney to oversee the rescheduling hearing and named 25 witnesses to participate in the proceeding. Questions arose regarding whether the DEA should be included in the hearing as the proponent, given its apparent bias against rescheduling, as evidenced by its collaboration with individuals who opposed rescheduling to enable them to be witnesses. Judge Mulrooney cancelled (stayed) the hearings until the challenge was settled or resolved.
Harrisburg, PA — Newly released data from the FBI’s Uniform Crime Reporting (UCR) Program shows that Pennsylvania police made 11,154 arrests for simple cannabis possession in 2024 alone, along with 1,553 arrests for cannabis sales/manufacturing.
According to the data, there have been 154,491 cannabis possession arrests and 27,222 arrests for cannabis sales/manufacturing in Pennsylvania over the last decade.
"Every cannabis arrest is a preventable tragedy that ruins lives, creating barriers to jobs, career paths, and housing long after sentences are complete. Arresting over 12,000 people per year for cannabis offenses also diverts taxpayer dollars and resources away from solving violent crimes and property offenses with victims. The data underscores the urgent need for state lawmakers to pass legislation that ends simple cannabis arrests, expunges past records, and creates a regulated adult-use market," said Karen O’Keefe, Director of State Policies at the Marijuana Policy Project.
Notably, Pennsylvania remains one of only 19 states where simple cannabis possession can still lead to jail time. Meanwhile, nearly all of Pennsylvania's neighboring states (with the exception of West Virginia) have legalized adult-use cannabis, creating regulated markets and generating significant tax revenue.
Pennsylvania lawmakers have proposed several bills to legalize, regulate, and tax cannabis for adults 21 and older in 2025. Reps. Rick Krajewski (D) and Dan Frankel’s (D) state-run stores bill, HB 1200, passed the House in a party-line vote in May, but it was killed in the Senate Law and Justice Committee days later. In July, Senate Law and Justice Committee Chairman Dan Laughlin (R) and Sen. Sharif Street (D) introduced a bipartisan cannabis legalization bill, SB 120, and Rep. Amen Brown (D) introduced companion bill HB 1735. Shortly after, Reps. Emily Kinkead (D) and Abby Major (R) introduced their bipartisan legalization bill, HB 20. Comparisons of the key aspects of the various proposals are available here.
Washington, D.C. — The Marijuana Policy Project (MPP), the nation’s leading cannabis policy organization, released an open letter to the cannabis industry today from Executive Director Adam J. Smith. Smith makes the case that robust independent advocacy is indispensable to industry's goals, and calls for a more strategic deployment of our collective political capital.
The letter explains that a vibrant and sustainable legal industry that includes rational regulation, reasonable taxation, and broad public access for adults and patients is the best antidote to dangerous, unregulated markets and is crucial to public health and safety. When the industry's profit incentives undercut its political credibility on these threshold issues, independent advocacy is uniquely qualified to make that case, particularly in the face of a resurgent neo-prohibitionist movement that is spreading shameful disinformation under the cynical mantle of "public health" and "protecting the children."
“A strong industry creates jobs, generates tax revenues, and revitalizes local economies. These arguments were, and still are, powerful incentives for reform. But they cannot finish the job of ending prohibition. They don’t speak to the deeper issues that first brought this movement together, nor can they speak with authority to address the concerns, including public health and safety, that many lawmakers and their constituents have about cannabis.”
The full letter is available here.